Variety chemotherapeutic drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Cell Line, Tumor Tumor Cells, Cultured Cell Line KB Cells HCT116 Cells Neoplastic Stem Cells HT29 Cells HL-60 Cells K562 Cells Cells, Cultured Mitochondria Hep G2 Cells HeLa Cells MCF-7 Cells Spheroids, Cellular T-Lymphocytes, Cytotoxic

Organisms7

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae Oncolytic Viruses Cricetinae

Diseases39

Neoplasms Neoplasms, Experimental Breast Neoplasms Melanoma, Experimental Lung Neoplasms Colonic Neoplasms Leukemia P388 Melanoma Sarcoma 180 Ovarian Neoplasms Leukemia L1210 Adenocarcinoma Liver Neoplasms Fibrosarcoma Neuroblastoma Prostatic Neoplasms Carcinoma, Hepatocellular Brain Neoplasms Mammary Neoplasms, Experimental Pancreatic Neoplasms Osteosarcoma Neovascularization, Pathologic Neoplasm Metastasis Disease Models, Animal Glioblastoma Glioma Lymphoma Carcinoma Leukemia Carcinoma, Lewis Lung Bone Neoplasms Sarcoma, Experimental Colorectal Neoplasms Carcinoma, Squamous Cell Multiple Myeloma Carcinoma, Non-Small-Cell Lung Necrosis Cell Transformation, Neoplastic Skin Neoplasms

Chemicals and Drugs111

Antineoplastic Agents Doxorubicin Antibiotics, Antineoplastic Cisplatin Paclitaxel Antineoplastic Agents, Phytogenic P-Glycoprotein Etoposide Fluorouracil Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 Daunorubicin Camptothecin Caspases Vinblastine Deoxycytidine Vincristine RNA, Small Interfering Apoptosis Regulatory Proteins Mitomycin Caspase 3 Cyclophosphamide Neoplasm Proteins TNF-Related Apoptosis-Inducing Ligand Enzyme Inhibitors Drug Carriers Multidrug Resistance-Associated Proteins bcl-X Protein Antibodies, Monoclonal Bleomycin Mitoxantrone Dacarbazine Taxoids Prodrugs RNA, Messenger Carmustine Receptors, TNF-Related Apoptosis-Inducing Ligand Teniposide Methotrexate Organoplatinum Compounds bcl-2-Associated X Protein ATP-Binding Cassette Transporters Inhibitor of Apoptosis Proteins Cancer Vaccines Angiogenesis Inhibitors Fenretinide Pyrazines Melphalan Cytarabine Boronic Acids Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Protein Kinase Inhibitors Antigens, CD95 Membrane Glycoproteins Nanoconjugates DNA, Neoplasm Topoisomerase II Inhibitors Dactinomycin Poly(ADP-ribose) Polymerases Radiation-Sensitizing Agents Recombinant Proteins Organoselenium Compounds Piperazines Chlorambucil Bridged Compounds Plant Extracts Caspase 8 Carboplatin DNA-Binding Proteins DNA Imidazoles Tumor Necrosis Factor-alpha Caspase 9 Quinazolines P-Glycoproteins Rhodamine 123 Protein-Serine-Threonine Kinases Antigens, Neoplasm NF-kappa B Flavonoids Fas Ligand Protein Caspase 7 Nuclear Proteins Sulfonamides Myeloid Cell Leukemia Sequence 1 Protein Enediynes Pyrimidines Ceramides Histone Deacetylase Inhibitors Reactive Oxygen Species Cyclin-Dependent Kinase Inhibitor p21 Carrier Proteins X-Linked Inhibitor of Apoptosis Protein Glutathione Transcription Factors Intracellular Signaling Peptides and Proteins TOR Serine-Threonine Kinases STAT3 Transcription Factor Cell Cycle Proteins Receptor, Epidermal Growth Factor Recombinant Fusion Proteins Cytochromes c Pyridines Indoles Proto-Oncogene Proteins c-mdm2 Polyethylene Glycols Tumor Suppressor Proteins Tubulin Modulators

Analytical, Diagnostic and Therapeutic Techniques and Equipment37

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasm Transplantation Neoplasms, Experimental Antineoplastic Combined Chemotherapy Protocols Inhibitory Concentration 50 Drug Delivery Systems Melanoma, Experimental Transplantation, Heterologous Blotting, Western Flow Cytometry Transfection Drug Carriers Immunotherapy Tumor Burden Drug Evaluation, Preclinical Combined Modality Therapy Genetic Therapy Reverse Transcriptase Polymerase Chain Reaction Electrochemotherapy Mammary Neoplasms, Experimental Tumor Stem Cell Assay Models, Biological Nanoconjugates Drug Administration Schedule Immunohistochemistry Disease Models, Animal Treatment Outcome Oncolytic Virotherapy Immunotherapy, Adoptive Immunoblotting Sarcoma, Experimental Injections, Intralesional Gene Knockdown Techniques Clinical Trials as Topic In Situ Nick-End Labeling Gene Expression Profiling

Phenomena and Processes48

Drug Resistance, Neoplasm Apoptosis Drug Synergism Cell Survival Drug Resistance, Multiple Cell Proliferation Dose-Response Relationship, Drug Inhibitory Concentration 50 Gene Expression Regulation, Neoplastic Cell Cycle DNA Damage Drug Resistance Signal Transduction Cell Division Transfection Cell Death Time Factors Down-Regulation Enzyme Activation Up-Regulation Cell Growth Processes RNA Interference Phosphorylation DNA Fragmentation Gene Expression Genetic Vectors DNA Repair Mutation Gene Silencing Protein Binding Base Sequence Genes, MDR Tissue Distribution Structure-Activity Relationship Molecular Structure Kinetics Amino Acid Sequence Cytotoxicity, Immunologic G2 Phase Membrane Potential, Mitochondrial Transcription, Genetic Autophagy Promoter Regions, Genetic Cell Movement Necrosis Phenotype Genes, p53 Cytoprotection

Disciplines and Occupations2

Nanomedicine Immunohistochemistry

Technology, Industry, Agriculture4

Nanomedicine Nanoconjugates Nanoparticles Polyethylene Glycols

Information Science3

Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care2

Treatment Outcome Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Cell Line, Tumor Doxorubicin Drug Screening Assays, Antitumor Drug Resistance, Neoplasm Antibiotics, Antineoplastic Apoptosis Xenograft Model Antitumor Assays Cisplatin Drug Synergism Tumor Cells, Cultured Neoplasms Mice, Nude Cell Survival Paclitaxel Antineoplastic Agents, Phytogenic Drug Resistance, Multiple Neoplasm Transplantation P-Glycoprotein Etoposide Cell Proliferation Fluorouracil Dose-Response Relationship, Drug Antineoplastic Agents, Alkylating Neoplasms, Experimental Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Inhibitory Concentration 50 Drug Delivery Systems Mice, Inbred BALB C Breast Neoplasms Proto-Oncogene Proteins c-bcl-2 Gene Expression Regulation, Neoplastic Tumor Suppressor Protein p53 Cell Cycle Mice, SCID Daunorubicin Melanoma, Experimental Camptothecin Caspases Lung Neoplasms DNA Damage Colonic Neoplasms Drug Resistance Vinblastine Leukemia P388 Deoxycytidine Signal Transduction Transplantation, Heterologous Vincristine Blotting, Western Cell Division RNA, Small Interfering Flow Cytometry Apoptosis Regulatory Proteins Mitomycin Transfection Caspase 3 Cyclophosphamide Cell Death Mice, Inbred C57BL Neoplasm Proteins TNF-Related Apoptosis-Inducing Ligand Time Factors Enzyme Inhibitors Drug Carriers Melanoma Multidrug Resistance-Associated Proteins bcl-X Protein Immunotherapy Tumor Burden Sarcoma 180 Ovarian Neoplasms Cell Line Antibodies, Monoclonal Bleomycin Drug Evaluation, Preclinical Mitoxantrone Dacarbazine Leukemia L1210 Taxoids Combined Modality Therapy Adenocarcinoma Prodrugs Down-Regulation RNA, Messenger Carmustine Receptors, TNF-Related Apoptosis-Inducing Ligand Nanomedicine Liver Neoplasms Fibrosarcoma Teniposide KB Cells Methotrexate Enzyme Activation Organoplatinum Compounds Up-Regulation Neuroblastoma bcl-2-Associated X Protein Genetic Therapy

No FAQ available that match "variety chemotherapeutic drug screening assays antitumor"